Clinical trial will test novel inhaled TB vaccine
Drug Discovery World
JANUARY 16, 2024
The Jenner Institute at the University of Oxford is conducting the study using Bacille Calmette-Guérin (BCG), the current licensed vaccine against TB. This important new study will help us to see whether giving BCG more than once stimulates a stronger immune response and whether giving it by inhalation is better than giving it into the skin.
Let's personalize your content